Sex-based differential regulation of oxidative stress in the vasculature by nitric oxide

Redox Biology

Volumn 4, Issue , 2015, Pages 226-233

  Morales, Rommel C ^a   Bahnson, Edward S M ^a   Havelka, George E ^a   Cantu Medellin, Nadiezhda ^b   Kelley, Eric E ^b   Kibbe, Melina R ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Neointimal hyperplasia; Nitric oxide; Sex differences; Superoxide; Vascular

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; NITRIC OXIDE DONOR; SOD1 PROTEIN, RAT; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ARTERY INJURY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; SMOOTH MUSCLE FIBER; SOD 1 GENE; VASCULARIZATION; ANIMAL; CAROTID ARTERY; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

RATTUS; RODENTIA;

ANIMALS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION; MALE; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; NITRIC OXIDE DONORS; OXIDATIVE STRESS; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE-1; SUPEROXIDES;

EID: 84921489035     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.01.007     Document Type: Article

References (45)

1. Ahanchi S.S., Tsihlis N.D., Kibbe M.R. The role of nitric oxide in the pathophysiology of intimal hyperplasia. Journal ofVascularSurgery 2007, 45(Suppl. A):A64-A73. http://www.ncbi.nlm.nih.gov/pubmed/17544026. 10.1016/j.jvs.2007.02.027.
2. Kibbe M.R., Li J., Nie S., Watkins S.C., Lizonova A., Kovesdi I., Simmons R.L., Billiar T.R., Tzeng E. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. Journal ofVascularSurgery 2000, 31(6):1214-1228. http://www.ncbi.nlm.nih.gov/pubmed/10842159. 10.1067/mva.2000.105006.
3. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288(5789):373-376. http://www.ncbi.nlm.nih.gov/pubmed/6253831. 10.1038/288373a0.
4. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327(6122):524-526. http://www.ncbi.nlm.nih.gov/pubmed/3495737. 10.1038/327524a0.
5. Radomski M.W., Palmer R.M., Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochemical andBiophysicalResearchCommunications 1987, 148(3):1482-1489. http://www.ncbi.nlm.nih.gov/pubmed/2825688. 10.1016/S0006-291X(87)80299-1.
6. Kubes P., Suzuki M., Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proceedings of theNationalAcadamy ofScincesUSA 1991, 88(11):4651-4655. http://www.ncbi.nlm.nih.gov/pubmed/1675786. 10.1073/pnas.88.11.4651.
7. Garg U.C., Hassid A. Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/c 3T3 fibroblasts by a cyclic GMP-independent mechanism. Biochemical andBiophysicalResearchCommunications 1990, 171(1):474-479. http://www.ncbi.nlm.nih.gov/pubmed/1697465. 10.1016/0006-291X(90)91417-Q.
8. Pollman M.J., Yamada T., Horiuchi M., Gibbons G.H. Vasoactive substances regulate vascular smooth muscle cell apoptosis. countervailing influences of nitric oxide and angiotensin II. CirculationResearch 1996, 79(4):748-756. http://www.ncbi.nlm.nih.gov/pubmed/8831498. 10.1161/01.RES.79.4.748.
9. Guo J.P., Panday M.M., Consigny P.M., Lefer A.M. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. AmericanJournal ofPhysiology 1995, 269(3 Pt 2):H1122-H1131. http://www.ncbi.nlm.nih.gov/pubmed/7573510.
10. Tzeng E., Kim Y.M., Pitt B.R., Lizonova A., Kovesdi I., Billiar T.R. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery 1997, 122(2):255-263. http://www.ncbi.nlm.nih.gov/pubmed/9288130. 10.1016/S0039-6060(97)90016-7.
11. Ziche M., Morbidelli L., Masini E., Amerini S., Granger H.J., Maggi C.A., Geppetti P., Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. Journal ofClinicalInvestigation 1994, 94(5):2036-2044. http://www.ncbi.nlm.nih.gov/pubmed/7525653. 10.1172/JCI117557.
12. Chaux A., Ruan X.M., Fishbein M.C., Ouyang Y., Kaul S., Pass J.A., Matloff J.M. Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation. Journal ofThoracic andCardiovascularSurgery 1998, 115(3):604-612. http://www.ncbi.nlm.nih.gov/pubmed/9535448. 10.1016/S0022-5223(98)70325-3.
13. Davies M.G., Dalen H., Kim J.H., Barber L., Svendsen E., Hagen P.O. Control of accelerated vein graft atheroma with the nitric oxide precursor: l-arginine. Journal ofSurgicalResearch 1995, 59(1):35-42. http://www.ncbi.nlm.nih.gov/pubmed/7630134. 10.1006/jsre.1995.1129.
14. Fleser P.S., Nuthakki V.K., Malinzak L.E., Callahan R.E., Seymour M.L., Reynolds M.M., Merz S.I., Meyerhoff M.E., Bendick P.J., Zelenock G.B., Shanley C.J. Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts. Journal ofVascularSurgery 2004, 40(4):803-811. http://www.ncbi.nlm.nih.gov/pubmed/15472611. 10.1016/j.jvs.2004.07.007.
15. Marks D.S., Vita J.A., Folts J.D., Keaney J.F., Welch G.N., Loscalzo J. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. Journal ofClincalInvestigation 1995, 96(6):2630-2638. http://www.ncbi.nlm.nih.gov/pubmed/8675628. 10.1172/JCI118328.
16. Lee J.S., Adrie C., Jacob H.J., Roberts J.D., Zapol W.M., Bloch K.D. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. CirculationResearch 1996, 78(2):337-342. http://www.ncbi.nlm.nih.gov/pubmed/8575078. 10.1161/01.RES.78.2.337.
17. Pearce C.G., Najjar S.F., Kapadia M.R., Murar J., Eng J., Lyle B., Aalami O.O., Jiang Q., Hrabie J.A., Saavedra J.E., Keefer L.K., Kibbe M.R. Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. Free RadicalBiology andMedicine 2008, 44(1):73-81. http://www.ncbi.nlm.nih.gov/pubmed/18045549. 10.1016/j.freeradbiomed.2007.09.010.
18. Shears L.L., Kibbe M.R., Murdock A.D., Billiar T.R., Lizonova A., Kovesdi I., Watkins S.C., Tzeng E. Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. Journal ofAmericanCollege ofSurgeons 1998, 187(3):295-306. http://www.ncbi.nlm.nih.gov/pubmed/9740187. 10.1016/S1072-7515(98)00163-X.
19. Vavra A.K., Havelka G.E., Martinez J., Lee V.R., Fu B., Jiang Q., Keefer L.K., Kibbe M.R. Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia. Nitric Oxide 2011, 25(1):22-30. http://www.ncbi.nlm.nih.gov/pubmed/21554972. 10.1016/j.niox.2011.04.013.
20. Von der Leyen H.E., Gibbons G.H., Morishita R., Lewis N.P., Zhang L., Nakajima M., Kaneda Y., Cooke J.P., Dzau V.J. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proceedings of theNationalAcademy ofSciencesUSA 1995, 92(4):1137-1141. http://www.ncbi.nlm.nih.gov/pubmed/7532305. 10.1073/pnas.92.4.1137.
21. Hogg M.E., Varu V.N., Vavra A.K., Popowich D.A., Banerjee M.N., Martinez J., Jiang Q., Saavedra J.E., Keefer L.K., Kibbe M.R. Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status. Free RadicalBiology andMedicine 2011, 50(9):1065-1074. http://www.ncbi.nlm.nih.gov/pubmed/21256959. 10.1016/j.freeradbiomed.2011.01.016.
22. Vassalle C., Sciarrino R., Bianchi S., Battaglia D., Mercuri A., Maffei S. Sex-related differences in association of oxidative stress status with coronary artery disease. Fertility andSterility 2012, 97(2):414-419. http://www.ncbi.nlm.nih.gov/pubmed/22196713. 10.1016/j.fertnstert.2011.11.045.
23. Jacobson G.M., Dourron H.M., Liu J., Carretero O.A., Reddy D.J., Andrzejewski T., Pagano P.J. Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery. Circulation Research 2003, 92(6):637-643. http://www.ncbi.nlm.nih.gov/pubmed/12609967. 10.1161/01.RES.0000063423.94645.8A.
24. Souza H.P., Souza L.C., Anastacio V.M., Pereira A.C., Junqueira M.L., Krieger J.E., da Luz P.L., Augusto O., Laurindo F.R. Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. Free RadicalBiologyand Medicine 2000, 28(8):1232-1242. http://www.ncbi.nlm.nih.gov/pubmed/10889453. 10.1016/S0891-5849(00)00240-9.
25. Azevedo L.C., Pedro M.A., Souza L.C., de Souza H.P., Janiszewski M., da Luz P.L., Laurindo F.R. Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. CardiovascularResearch 2000, 47(3):436-445. http://www.ncbi.nlm.nih.gov/pubmed/10963717. 10.1016/S0008-6363(00)00091-2.
26. 2-elevated by oxidized LDL enhances human aortic smooth muscle cell proliferation. Journal ofBiomedicineScience 2007, 14(2):245-254. http://www.ncbi.nlm.nih.gov/pubmed/17124566. 10.1007/s11373-006-9132-4.
27. Jeong H.Y., Jeong H.Y., Kim C.D. p22phox-derived superoxide mediates enhanced proliferative capacity of diabetic vascular smooth muscle cells. Diabetes Research andClinicalPractice 2004, 64(1):1-10. http://www.ncbi.nlm.nih.gov/pubmed/15036821. 10.1016/j.diabres.2003.10.004.
28. Haurani M.J., Pagano P.J. Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease?. CardiovascularResearch 2007, 75(4):679-689. http://www.ncbi.nlm.nih.gov/pubmed/17689510. 10.1016/j.cardiores.2007.06.016.
29. Kuo M.D., Bright I.J., Wang D.S., Ghafouri P., Yuksel E., Hilfiker P.R., Miniati D.N., Dake M.D. Local resistance to oxidative stress by overexpression of copper-zinc superoxide dismutase limits neointimal formation after angioplasty. Journal ofEndovascularTherapy 2004, 11(6):585-594. http://www.ncbi.nlm.nih.gov/pubmed/15615548. 10.1583/04-1310.1.
30. Muscoli C., Sacco I., Alecce W., Palma E., Nisticò R., Costa N., Clementi F., Rotiroti D., Romeo F., Salvemini D., Mehta J.L., Mollace V. The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: role of the lectin-like oxidized low-density lipoprotein receptor-1. Journal ofPharmacology andExperiemntalTherapeutics 2004, 311(1):44-50. http://www.ncbi.nlm.nih.gov/pubmed/15220383. 10.1124/jpet.104.068205.
31. Bahnson E.S.M., Koo N., Cantu-Medellin N., Tsui A.Y., Havelka G.E., Vercammen J.M., Jiang Q., Kelley E.E., Kibbe M.R. Nitric oxide inhibits neointimal hyperplasia following vascular injury via differential, cell-specific modulation of SOD-1 in the arterial wall. Nitric Oxide 2015, 44:8-17. 10.1016/j.niox.2014.10.009.
32. Keefer L.K. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates. AnnualReview ofPharmacology andToxicology 2003, 43:585-607. http://www.ncbi.nlm.nih.gov/pubmed/12415121. 10.1146/annurev.pharmtox.43.100901.135831.
33. Gunther S., Alexander R.W., Atkinson W.J., Gimbrone M.A. Functional angiotensin II receptors in cultured vascular smooth muscle cells. Journal ofCell Biology 1982, 92(2):289-298. http://www.ncbi.nlm.nih.gov/pubmed/6277961. 10.1083/jcb.92.2.289.
34. Dikalov S.I., Li W., Mehranpour P., Wang S.S., Zafari A.M. Production of extracellular superoxide by human lymphoblast cell lines: comparison of electron spin resonance techniques and cytochrome C reduction assay. BiochemicalPharmacology 2007, 73(7):972-980. http://www.ncbi.nlm.nih.gov/pubmed/17222393. 10.1016/j.bcp.2006.12.012.
35. Zielonka J., Vasquez-Vivar J., Kalyanaraman B. Detection of 2-hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine. NatureProtocols 2008, 3(1):8-21. http://www.ncbi.nlm.nih.gov/pubmed/18193017. 10.1038/nprot.2007.473.
36. Hirschberg K., Radovits T., Korkmaz S., Loganathan S., Zöllner S., Seidel B., Páli S., Barnucz E., Merkely B., Karck M., Szabó G. Combined superoxide dismutase mimetic and peroxynitrite scavenger protects against neointima formation after endarterectomy in association with decreased proliferation and nitro-oxidative stress. EuropeanJournal ofVascular andEndovascularSurgery 2010, 40(2):168-175. http://www.ncbi.nlm.nih.gov/pubmed/20434373. 10.1016/j.ejvs.2010.03.024.
37. Wang J.-N., Shi N., Chen S.-Y. Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells. Free RadicalBiology andMedicine 2012, 52(1):173-181. http://www.ncbi.nlm.nih.gov/pubmed/22062629. 10.1016/j.freeradbiomed.2011.10.442.
38. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. Journal American Medical Association 1991, 265(14):1861-1867. http://www.ncbi.nlm.nih.gov/pubmed/2005736. 10.1001/jama.265.14.1861.
39. Lam K.-K., Lee Y.-M., Hsiao G., Chen S.-Y., Yen M.-H. Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats. Menopause 2006, 13(2):294-302. http://www.ncbi.nlm.nih.gov/pubmed/16645543. 10.1097/01.gme.0000182806.99137.5e.
40. McNeill A.M., Kim N., Duckles S.P., Krause D.N., Kontos H.A. Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 1999, 30(10):2186-2190. http://www.ncbi.nlm.nih.gov/pubmed/10512927. 10.1161/01.STR.30.10.2186.
41. Stirone C., Chu Y., Sunday L., Duckles S.P., Krause D.N. 17 Beta-estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction. EuropeanJournal ofPharmacology 2003, 478(1):35-38. http://www.ncbi.nlm.nih.gov/pubmed/14555182. 10.1016/j.ejphar.2003.08.037.
42. Arias-Loza P.-A., Muehlfelder M., Pelzer T. Estrogen and estrogen receptors in cardiovascular oxidative stress. Pflugers Archives 2013, 465(5):739-746. http://www.ncbi.nlm.nih.gov/pubmed/23417608. 10.1007/s00424-013-1247-7.
43. Strehlow K., Rotter S., Wassmann S., Adam O., Grohé C., Laufs K., Böhm M., Nickenig G. Modulation of antioxidant enzyme expression and function by estrogen. CirculationResearch 2003, 93(2):170-177. http://www.ncbi.nlm.nih.gov/pubmed/12816884. 10.1161/01.RES.0000082334.17947.11.
44. Wedgwood S., Black S.M. Molecular mechanisms of nitric oxide-induced growth arrest and apoptosis in fetal pulmonary arterial smooth muscle cells. Nitric Oxide 2003, 9(4):201-210. http://www.ncbi.nlm.nih.gov/pubmed/14996427. 10.1016/j.niox.2003.11.005.
45. Michalski R., Michalowski B., Sikora A., Zielonka J., Kalyanaraman B. On the use of fluorescence lifetime imaging and dihydroethidium to detect superoxide in intact animals and ex vivo tissues: a reassessment. Free RadicalBiology andMedicine 2014, 67:278-284. http://www.ncbi.nlm.nih.gov/pubmed/24200598. 10.1016/j.freeradbiomed.2013.10.816.